These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6612854)

  • 21. Classification of cutaneous intravascular breast cancer metastases based on immunolabeling for blood and lymph vessels.
    Marneros AG; Blanco F; Husain S; Silvers DN; Grossman ME
    J Am Acad Dermatol; 2009 Apr; 60(4):633-8. PubMed ID: 19293011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous metastases from different internal malignancies: a clinical and prognostic appraisal.
    Hu SC; Chen GS; Lu YW; Wu CS; Lan CC
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):735-40. PubMed ID: 18312322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy.
    Morris KT; Toth-Fejel S; Schmidt J; Fletcher WS; Pommier RF
    Surgery; 2001 Dec; 130(6):947-53. PubMed ID: 11742322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrochemotherapy treatment of cutaneous metastases from breast cancer.
    Mercantini P; Lorenzon L; Tarantino G; Balducci G; Ferri M; Mazzuca F; Botticelli A; Marchetti P
    Am Surg; 2015 May; 81(5):E222-5. PubMed ID: 25975317
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of the preparation Orimeten in the treatment of advanced cases of breast cancer in women].
    Bassara H; Ramlau C
    Nowotwory; 1987; 37(2):148-53. PubMed ID: 3313288
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of vindesine in lymphangitic-type cutaneous recurrence of breast cancer].
    Palangie T; Jouve M; Giralt E; Bretaudeau B; Pouillart P
    Bull Cancer; 1983; 70(5):437-8. PubMed ID: 6582941
    [No Abstract]   [Full Text] [Related]  

  • 27. [[Treatment with Miltex for metastatic skin lesions in breast cancer] ].
    Moĭseenko VM; Orlova RV; Ermakova NA; Protsenko SA
    Vopr Onkol; 2000; 46(5):600-3. PubMed ID: 11202195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Aminoglutethimide - a new drug for the after care in breast cancer].
    Rabe T; Rabe D; Runnebaum B
    Fortschr Med; 1981 Nov; 99(43):1816-8. PubMed ID: 7308944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of advanced breast cancer with aminoglutethimide].
    Lønning PE; Kvinnsland S
    Tidsskr Nor Laegeforen; 1984 Nov; 104(31):2185-7. PubMed ID: 6531774
    [No Abstract]   [Full Text] [Related]  

  • 30. Cutaneous metastasis of breast carcinoma mimicking malignant melanoma in scalp.
    Martí N; Molina I; Monteagudo C; López V; García L; Jordá E
    Dermatol Online J; 2008 Nov; 14(11):12. PubMed ID: 19094850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin clues to primary and metastatic malignancy.
    Cohen PR
    Am Fam Physician; 1995 Apr; 51(5):1199-204. PubMed ID: 7709895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zosteriform cutaneous metastases from breast adenocarcinoma.
    Bassioukas K; Nakuci M; Dimou S; Kanellopoulou M; Alexis I
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):593-6. PubMed ID: 16164715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
    Smith IE; Harris AL; Morgan M; Gazet JC; McKinna JA
    Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
    Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
    Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Compressive dyspnea and dysphagia caused by sclerous cervical cutaneous metastasis disclosing breast carcinoma].
    Audeguy P; Leclech C; Lortholary A; Mège M; Berrut G; Croué A; Fressinaud P
    Ann Dermatol Venereol; 1997; 124(3):245-7. PubMed ID: 9686057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aminoglutethimide in the treatment of advanced postmenopausal breast cancer.
    Harris AL; Powles TJ; Smith IE
    Cancer Res; 1982 Aug; 42(8 Suppl):3405s-3408s. PubMed ID: 7083207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical skin metastases from early tubular breast carcinoma.
    Cil T; Altintas A; Pasa S; Isikdogan A
    Int J Dermatol; 2008 Dec; 47(12):1311-3. PubMed ID: 19126026
    [No Abstract]   [Full Text] [Related]  

  • 38. [Unusual metastases of breast cancer].
    Abboud B; Sayegh R; Ingea H; Tohme C; Farah P
    J Chir (Paris); 1995 Feb; 132(2):94-9. PubMed ID: 7751348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ulcerative carcinoma of the breast with zosteriform skin metastases.
    Torchia D; Palleschi GM; Terranova M; Antiga E; Melani L; Caproni M; Fabbri P
    Breast J; 2006; 12(4):385. PubMed ID: 16848856
    [No Abstract]   [Full Text] [Related]  

  • 40. Miltefosine: new preparation. Solution for cutaneous application.
    Prescrire Int; 1998 Feb; 7(33):5-6. PubMed ID: 10183390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.